Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study | Zendy

Mark H. Wilcox | Zendy; Oliver A. Cornely | Zendy; Benoît Guéry | Zendy; Christopher Longshaw | Zendy; Areti Georgopali | Zendy; Andreas Karas | Zendy; Gbenga Kazeem | Zendy; José Palacios | Zendy; Maria J. G. T. Vehreschild | Zendy

Open Access

Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study

Author(s) -

Mark H. Wilcox,

Oliver A. Cornely,

Benoît Guéry,

Christopher Longshaw,

Areti Georgopali,

Andreas Karas,

Gbenga Kazeem,

José Palacios,

Maria J. G. T. Vehreschild

Publication year - 2019

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofz436

Subject(s) - fidaxomicin , clostridium difficile , coinfection , medicine , clostridioides , vancomycin , gastroenterology , clinical significance , microbiology and biotechnology , immunology , antibiotics , human immunodeficiency virus (hiv) , biology , staphylococcus aureus , bacteria , genetics

Testing for presence of copathogens in clinical trials of antibiotics could help to explain clinical failures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research